[1] DE KOUCHKOVSKY I,ABDUL-HAY M.Acute myeloid leukemia:a comprehensive review and 2016 update[J].Blood Cancer J,2016,6(7):e441. [2] MEDEIROS B C.Is there a standard of care for relapsed AML?[J].Best Pract Res Clin Haematol,2018,31(4):384-386. [3] TANG Y,PAN J,HUANG S,et al.Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling[J].J Exp Clin Cancer Res,2018,37(1):160. [4] ZHOU G Q,HAN F,SHI Z L,et al.miR-133a-3p targets SUMO-specific protease 1 to inhibit cell proliferation and cell cycle progress in colorectal cancer[J].Oncol Res,2018,26(5):795-800. [5] HE B,LIN X,TIAN F,et al.miR-133a-3p inhibits oral squamous cell carcinoma(OSCC)proliferation and invasion by suppressing COL1 A1[J].J Cell Biochem,2018,119(1):338-346. [6] LI J,LIU X,WANG W,et al.miR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma[J].Arch Med Sci,2020,16(4):941-956. [7] YIN Y,DU L,LI X,et al.miR-133a-3p suppresses cell proliferation,migration,and invasion and promotes apoptosis in esophageal squamous cell carcinoma[J].J Cell Physiol,2019,234(8):12757-12770. [8] 陈春销,李双月.匹莫齐特在急性髓系白血病中的作用机制[J].医学分子生物学杂志,2025,22(3):300-304. CHEN C X,LI S Y.Mechanism of pimozide in acute myeloid leukemia[J].J Med Mol Biol,2025,22(3):300-304. [9] 马丽娜,郝建萍,张瑞,等.MCL1调控GSK3β/Wnt/β-catenin信号轴促进急性T淋巴细胞白血病细胞对维奈克拉耐药的机制研究[J].医学分子生物学杂志,2025,22(4):325-331. MA L N,HAO J P,ZHANG R,et al.MCL1 promotes drug resistance of acute T lymphoblastic leukemia cells to venetoclax by regulating GSK3β/wnt/β-catenin axis[J].J Med Mol Biol,2025,22(4):325-331. [10] WYSOTA M,KONOPLEVA M,MITCHELL S.Novel therapeutic targets in acute myeloid leukemia(AML)[J].Curr Oncol Rep,2024,26(4):409-420. [11] HUBER S,BAER C,HUTTER S,et al.AML classification in the year 2023:How to avoid a Babylonian confusion of languages[J].Leukemia,2023,37(7):1413-1420. [12] HUANG Y,WU Y,DONG J,et al.microRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ[J].Am J Cancer Res,2016,6(11):2448-2462. [13] YANG Q,SONG C,WANG P,et al.Polymorphism of TUSC7 associated with gastric cancer susceptibility and binding with miR-133a-3p:a population-based case-control study[J].Int J Clin Oncol,2021,26(8):1469-1476. [14] SHI W,TANG T,LI X,et al.Methylation-mediated silencing of miR-133a-3p promotes breast cancer cell migration and stemness via miR-133a-3p/MAML1/DNMT3 A positive feedback loop[J].J Exp Clin Cancer Res,2019,38(1):429. [15] YANG X,YU F,HUANG G,et al.Exosomal miR-133a-3p promotes the growth and metastasis of lung cancer cells following incomplete microwave ablation[J].Int J Hyperthermia,2023,40(1):2190065. [16] LI Q,WANG Y,HE J.miR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5[J].J Clin Lab Anal,2021,35(7):e23853. [17] HU Y,YU H,SHAW G,et al.Differential roles of TGIF family genes in mammalian reproduction[J].BMC Dev Biol,2011,11:58. [18] DU R,SHEN W,LIU Y,et al.TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness[J].Sig Transduct Target Ther,2019,4:60. [19] JIANG J,WU R H,ZHOU H L,et al.TGIF2 promotes cervical cancer metastasis by negatively regulating FCMR[J].Eur Rev Med Pharmacol Sci,2020,24(11):5953-5962. [20] LU Y J,LIU R Y,HU K,et al.miR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer[J].Tumour Biol,2016,37(9):12685-12695. [21] HU Y,PU Q,CUI B,et al.microRNA-34 a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2[J].Int J Clin Exp Pathol,2015,8(8):8921-8928. [22] DIAO Y,JIN B,HUANG L,et al.miR-129-5 p inhibits glioma cell progression in vitro and in vivo by targeting TGIF2[J].J Cell Mol Med,2018,22(4):2357-2367. |